Common Causes of Hearing Loss in Children

Hearing loss in children can be caused by various factors. One of the most common causes is otitis media with effusion (OME), which is prevalent in younger children due to their shorter and more horizontal Eustachian tube, making it easier for bacteria to enter and harder for drainage. However, vestibular schwannomas (acoustic neuromas) and otosclerosis are more likely to be diagnosed in middle-aged patients rather than young children. Foreign object insertion and perforated tympanic membrane are also possible causes of hearing loss, but not as common as OME in children. It is essential to identify the cause of hearing loss in children to provide appropriate treatment and prevent further complications.

Fragile X Syndrome: A Genetic Disorder

Fragile X syndrome is a genetic disorder caused by a trinucleotide repeat. It affects both males and females, but males are more severely affected. Common features in males include learning difficulties, large low set ears, long thin face, high arched palate, macroorchidism, hypotonia, and a higher likelihood of autism. Mitral valve prolapse is also a common feature. Females, who have one fragile chromosome and one normal X chromosome, may have a range of symptoms from normal to mild.

Diagnosis of Fragile X syndrome can be made antenatally by chorionic villus sampling or amniocentesis. The number of CGG repeats can be analyzed using restriction endonuclease digestion and Southern blot analysis. Early diagnosis and intervention can help manage the symptoms of Fragile X syndrome and improve the quality of life for those affected.

Marfan syndrome is a connective tissue disease with cardiovascular complications such as aortic root dilation and aneurysm. Diagnosis is based on clinical features, family history, and genetic testing. The Ghent criteria are commonly used, with emphasis on cardiac manifestations. Echocardiographic surveillance is required, and prophylactic medications are used to reduce the chance of aortic root dilation. Aortic regurgitation may require surgery. Marfan syndrome is associated with non-cardiac features, and the clinical criteria can be found on the American National Marfan Foundation website.

Managing Asthma in Children: NICE Guidelines

Asthma management in children has been updated by NICE in 2017, following the 2016 BTS guidelines. The new guidelines for children aged 5-16 are similar to those for adults, with a stepwise approach for treatment. For newly-diagnosed asthma, short-acting beta agonist (SABA) is recommended. If symptoms persist, a combination of SABA and paediatric low-dose inhaled corticosteroid (ICS) is used. Leukotriene receptor antagonist (LTRA) is added if symptoms still persist, followed by long-acting beta agonist (LABA) if necessary. Maintenance and reliever therapy (MART) is used as a combination of ICS and LABA for daily maintenance therapy and symptom relief. For children under 5 years old, clinical judgement plays a greater role in diagnosis. The stepwise approach is similar to that for older children, with an 8-week trial of paediatric moderate-dose ICS before adding LTRA. If symptoms persist, referral to a paediatric asthma specialist is recommended.

It should be noted that NICE does not recommend changing treatment for well-controlled asthma patients simply to adhere to the latest guidelines. The definitions of low, moderate, and high-dose ICS have also changed, with different definitions for adults and children. For children, <= 200 micrograms budesonide or equivalent is considered a paediatric low dose, 200-400 micrograms is a moderate dose, and > 400 micrograms is a high dose. Overall, the new NICE guidelines provide a clear and concise approach to managing asthma in children.

Capacity to make decisions is dependent on both time and the individual’s ability to make decisions. If the patient did not have the capacity to make a decision in the past, but currently has the capacity to do so, their consent is the only one required. It is advisable to involve parents in the decision-making process for pediatric patients, especially in cases involving contraception. However, if the patient is not convinced, the treatment can still proceed as long as they have the capacity to make the decision. If there are doubts, it is good practice to involve another healthcare team member, but if the patient is deemed capable of making the decision, their capacitous consent is sufficient according to the GMC. There is no requirement for a time gap between consultations to allow for decision-making.

Guidelines for Obtaining Consent in Children

The General Medical Council has provided guidelines for obtaining consent in children. According to these guidelines, young people who are 16 years or older can be treated as adults and are presumed to have the capacity to make decisions. However, for children under the age of 16, their ability to understand what is involved determines whether they have the capacity to decide. If a competent child refuses treatment, a person with parental responsibility or the court may authorize investigation or treatment that is in the child’s best interests.

When it comes to providing contraceptives to patients under 16 years of age, the Fraser Guidelines must be followed. These guidelines state that the young person must understand the professional’s advice, cannot be persuaded to inform their parents, is likely to begin or continue having sexual intercourse with or without contraceptive treatment, and will suffer physical or mental health consequences without contraceptive treatment. Additionally, the young person’s best interests require them to receive contraceptive advice or treatment with or without parental consent.

Some doctors use the term Fraser competency when referring to contraception and Gillick competency when referring to general issues of consent in children. However, rumors that Victoria Gillick removed her permission to use her name or applied copyright have been debunked. It is important to note that in Scotland, those with parental responsibility cannot authorize procedures that a competent child has refused.

Pyloric Stenosis: Characteristics and Biochemical Abnormalities

Pyloric stenosis is a condition commonly observed in male infants at around 5 weeks old, with an incidence rate of approximately 4 per 1000. It is often seen in first-born babies. The condition is characterized by the narrowing of the pylorus, the opening between the stomach and the small intestine, which causes difficulty in food passage.

One of the typical biochemical abnormalities observed in patients with pyloric stenosis is hypokalaemic hypochloraemic alkalosis, which is caused by the loss of hydrogen and chloride ions in the vomit. This results in an acidic urine. The imbalance of electrolytes in the body can lead to dehydration, weakness, and other complications. Early diagnosis and treatment are crucial to prevent further health problems.

Perthes’ disease is a condition that affects the hip joints of children, typically between the ages of 4 and 8. It is more common in boys and presents with symptoms such as hip pain, limping, and reduced range of motion. However, if Perthes’ disease occurs in children under the age of 6, it has a good prognosis and can be managed with observation and follow-up. Therefore, this is the preferred management choice. Open reduction and internal fixation, splinting, and the use of a Pavlik harness are not appropriate treatments for Perthes’ disease in children under 6 years old.

Understanding Perthes’ Disease

Perthes’ disease is a degenerative condition that affects the hip joints of children, typically between the ages of 4-8 years. It is caused by a lack of blood supply to the femoral head, which leads to bone infarction and avascular necrosis. This condition is more common in boys, with around 10% of cases being bilateral. The symptoms of Perthes’ disease include hip pain, stiffness, reduced range of hip movement, and a limp. Early changes can be seen on an x-ray, such as widening of the joint space, while later changes include decreased femoral head size and flattening.

To diagnose Perthes’ disease, a plain x-ray is usually sufficient. However, if symptoms persist and the x-ray is normal, a technetium bone scan or magnetic resonance imaging may be necessary. If left untreated, Perthes’ disease can lead to complications such as osteoarthritis and premature fusion of the growth plates.

The severity of Perthes’ disease is classified using the Catterall staging system, which ranges from stage 1 (clinical and histological features only) to stage 4 (loss of acetabular integrity). Treatment options include keeping the femoral head within the acetabulum using a cast or braces, observation for children under 6 years old, and surgical management for older children with severe deformities. The prognosis for Perthes’ disease is generally good, with most cases resolving with conservative management. Early diagnosis is key to improving outcomes.

The primary reason for stridor in infants is laryngomalacia, which is characterized by a soft epiglottis that collapses into the airway during inhalation. Although it typically resolves on its own, if the stridor worsens and causes respiratory distress or hinders feeding, surgery may be necessary to enhance the airway.

Stridor in Children: Causes and Symptoms

Stridor is a high-pitched, wheezing sound that occurs during breathing and is commonly seen in children. There are several causes of stridor in children, including croup, acute epiglottitis, inhaled foreign body, and laryngomalacia. Croup is a viral infection that affects the upper respiratory tract and is characterized by stridor, barking cough, fever, and coryzal symptoms. Acute epiglottitis is a rare but serious infection caused by Haemophilus influenzae type B, which can lead to airway obstruction. Inhaled foreign body can cause sudden onset of coughing, choking, vomiting, and stridor, depending on the site of impaction. Laryngomalacia is a congenital abnormality of the larynx that typically presents at 4 weeks of age with stridor.

It is important to recognize the symptoms of stridor in children and seek prompt medical attention, especially if the child appears unwell or toxic. Treatment may include medications, such as corticosteroids or nebulized epinephrine, or in severe cases, intubation or tracheostomy. Prevention measures, such as vaccination against Haemophilus influenzae type B, can also help reduce the incidence of acute epiglottitis. Overall, early recognition and management of stridor in children can help prevent complications and improve outcomes.

According to NICE guidelines, if a patient has developed a cough within the last 21 days and does not require hospitalization, macrolide antibiotics such as azithromycin or clarithromycin should be prescribed for children over 1 month old and non-pregnant adults. In this case, the patient does not meet the criteria for hospitalization due to their age, breathing difficulties, or complications. Along with antibiotics, patients should be advised to rest, stay hydrated, and use pain relievers like paracetamol or ibuprofen for symptom relief.

Whooping Cough: Causes, Symptoms, Diagnosis, and Management

Whooping cough, also known as pertussis, is a contagious disease caused by the bacterium Bordetella pertussis. It is commonly found in children, with around 1,000 cases reported annually in the UK. The disease is characterized by a persistent cough that can last up to 100 days, hence the name cough of 100 days.

Infants are particularly vulnerable to whooping cough, which is why routine immunization is recommended at 2, 3, 4 months, and 3-5 years. However, neither infection nor immunization provides lifelong protection, and adolescents and adults may still develop the disease.

Whooping cough has three phases: the catarrhal phase, the paroxysmal phase, and the convalescent phase. The catarrhal phase lasts around 1-2 weeks and presents symptoms similar to a viral upper respiratory tract infection. The paroxysmal phase is characterized by a severe cough that worsens at night and after feeding, and may be accompanied by vomiting and central cyanosis. The convalescent phase is when the cough subsides over weeks to months.

To diagnose whooping cough, a person must have an acute cough that has lasted for 14 days or more without another apparent cause, and have one or more of the following features: paroxysmal cough, inspiratory whoop, post-tussive vomiting, or undiagnosed apnoeic attacks in young infants. A nasal swab culture for Bordetella pertussis is used to confirm the diagnosis, although PCR and serology are increasingly used.

Infants under 6 months with suspected pertussis should be admitted, and in the UK, pertussis is a notifiable disease. An oral macrolide, such as clarithromycin, azithromycin, or erythromycin, is indicated if the onset of the cough is within the previous 21 days to eradicate the organism and reduce the spread. Household contacts should be offered antibiotic prophylaxis, although antibiotic therapy has not been shown to alter the course of the illness. School exclusion is recommended for 48 hours after commencing antibiotics or 21 days from onset of symptoms if no antibiotics are given.

Complications of whooping cough include subconjunctival haemorrhage, pneumonia, bronchiectasis, and

Fetal alcohol syndrome is a condition that occurs when a mother abuses alcohol during pregnancy. This can lead to various physical and developmental abnormalities in the fetus, including intrauterine growth restriction, small head size, underdeveloped midface, small jaw, a smooth ridge between the nose and upper lip, small eye openings, and a thin upper lip. Affected infants may also exhibit irritability and attention deficit hyperactivity disorder (ADHD).

Understanding Fetal Alcohol Syndrome

Fetal alcohol syndrome is a condition that occurs when a pregnant woman consumes alcohol, which can lead to various physical and mental abnormalities in the developing fetus. At birth, the baby may exhibit symptoms of alcohol withdrawal, such as irritability, hypotonia, and tremors.

The features of fetal alcohol syndrome include a short palpebral fissure, a thin vermillion border or hypoplastic upper lip, a smooth or absent philtrum, learning difficulties, microcephaly, growth retardation, epicanthic folds, and cardiac malformations. These physical characteristics can vary in severity and may affect the child’s overall health and development.

It is important for pregnant women to avoid alcohol consumption to prevent fetal alcohol syndrome and other potential complications. Early diagnosis and intervention can also help improve outcomes for children with fetal alcohol syndrome. By understanding the risks and consequences of alcohol use during pregnancy, we can work towards promoting healthier pregnancies and better outcomes for children.